Why It's Time to Take Electrified Medicine Seriously
Time Magazine | October 24, 2019 | Alice Park
We at JWLABS have been instructed NOT to make any statements pertaining to the effects of Rife technology on the structure/function of the human body. However, we believe we have the right to cite credible sources that highlight the many applications of electro-stimulation. Many benefits have long been known with respect to delivering electro-stimulation to the body and we have numerous customers who can testify to this. Unfortunately, the powers that be admonish us from telling their stories.
We cite this article for those wishing to learn more about the rationale for employing Rife technology as they seek to improve their general state of wellness. Note how this article illustrates that Big Pharma is already invested in producing devices based on the principles of Rife technology, which were established decades ago. It is our view that the big players do not want you to know that you can have an instrument in your home for personal use that may help you take back the power regarding your general well-being.
Below are some highlights from an article in mainstream news. We also encourage you to read the FULL ARTICLE.
“…While some bioelectric, or electroceutical, therapies already exist to treat conditions such as headaches, certain causes of depression, as well as chronic sinus pain, the new wave of electricity-based strategies could expand to help people with some of the most widespread chronic diseases in the world, including high blood pressure, arthritis, diabetes, some forms of blindness and even dementia.”
“…Such promise is already attracting scores of startups and major drug companies. Even with the still rudimentary efforts at stimulating some of the larger nerves in the body to treat, for example, headaches and chronic pain, financial analysts expect the market to reach $7 billion by 2025. (Emphasis ours.) Companies like Abbot already have neuromodulation devices designed to stimulate nerves, approved by the Food and Drug Administration, for treating chronic pain. The potential of the electroceutical field is part of a profound shift in the pharmaceutical industry, which has long been focused primarily on developing new pills. But as blockbuster drug development has stalled in recent years, established pharmaceutical companies like Glaxo- Smith-Kline see electroceuticals as a way to mine a new source of therapeutic possibility – —through nondrug treatments that rely more heavily on device and procedure-based methods….”
“There has been frustration that for many diseases for which we make new drugs, there hasn’t been tremendous progress,” says Dr. Brian Litt, professor of neurology and director of the Penn Epilepsy Center at the University of Pennsylvania. If more of the chronic diseases that continue to command the most prescriptions and health care services can be treated with bioelectronic approaches, the market for the field could approach $40 billion.“(Emphasis ours.)
“….Electoceuticals are the next wave of new treatments we will have to treat disease,’ says Kris Famm, president of Galvani Bioelectronics, a biotech corporation between GLaxoSmithKline and Google’s Verily that is focused on developing electricity-based therapies….” (Could this be why Google bumped JWLABS from page one to page 20 + in their organic listing with their algorithm change in August of 2018? Just asking…)
“…The idea of tapping into the body’s electrical network is centuries old. In the late 1700s, Italian scientist Luigi Galvani was walking through an open market during a lightning storm when he noticed that frog legs for sale were still twitching. Intrigued, he conducted among the first studies of electrical stimulation, using an electrode to pass a current through a frog leg and observing that the signal promoted the muscle to move.”
“…It turns out that many cellular functions — producing hormones, for example, or contracting or expanding muscles — are regulated by electrical signals that pass through the nerves between the brain and the organs where the cells are located. The frequency of those currents determines how active the cells are in performing their assigned function…”
“…As researchers have learned more about how cells communicate electronically with one another, they are fueling a more sophisticated surge in bioelectronic devices that is delving deeper into more complicated neural networks. Innovations in engineering that are packing chips and other electronic components into tinier and tinier kits to implant in the body, with more power to communicate, charge, stimulate and record, are also expanding the range of diseases that might be treated with a bioelectronic therapy.”
“…Nerves in the body that regulate specific organs – really specific cells in those organs – could be controlled with the precision of an orchestra conductor calling on specific instruments to generate just the right harmony. “The nervous system really uses electricity as its language”, says Robert Kirsch, chair of biomedical engineering at Case Western Reserve University and executive director of the Cleveland FES Center. ‘So electrical stimulation can be used theoretically just about anywhere in the nervous system. We need to learn how to speak that language.'”
Additional Articles of Interest